Firms, funds, people, portfolio companies and transactions from sworn filings and cited announcements, kept as a graph with a date and a source on every edge. Reported gross assets are never fund size, regulatory AUM is never dry powder, and a deal value prints only when someone disclosed it.

The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.

Transactions / O•••••• S•••••••

Clinisys Acquires O•••••• S•••••••

Exit to a strategic buyerannouncedannounced Jul 29, 2025Fact
What happened
Platform
not an add-on on record
Control
unknown
Share acquired
unknown
Industry
technology / software
Target location
unknown
Seller kind
Sponsor
Rollover
unknown
Values, only where disclosed
Enterprise value
Not disclosed
Purchase price
Not disclosed
Equity value
Not disclosed
Target revenue
Not disclosed
Target EBITDA
Not disclosed
Multiple
Not disclosed
Parties and roles
6 named
Buy side
  • C•••••••Strategic acquirerconfirmed
    Clinisys today announces the acquisition of O•••••• S••••••• from F•••••••• P•••••••, a leading global investment firm that specializes in partnering with technology businesses.
  • “We are incredibly proud to have partnered with O•••••• and supported its growth story over the past few years,” said A••••• M••••••••, Principal at F•••••••• P•••••••.
Sell side
  • Clinisys today announces the acquisition of O•••••• S••••••• from F•••••••• P•••••••, a leading global investment firm that specializes in partnering with technology businesses.
Advisory side
  • K••••••• • E•••• L••Legal adviserconfirmed
    A•••• P••••••• served as the exclusive financial advisor and K••••••• • E•••• L•• served as the legal advisor to F•••••••• P••••••• and O•••••• S•••••••.
  • A•••• P•••••••Sell-side adviserconfirmed
    A•••• P••••••• served as the exclusive financial advisor and K••••••• • E•••• L•• served as the legal advisor to F•••••••• P••••••• and O•••••• S•••••••.
Side not stated
  • Clinisys today announces the acquisition of O•••••• S••••••• from F•••••••• P•••••••, a leading global investment firm that specializes in partnering with technology businesses.
Evidence
Clinisys today announces the acquisition of O•••••• S••••••• from F•••••••• P•••••••, a leading global investment firm that specializes in partnering with technology businesses.